Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ORD SHS
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
13,970,280
-
Shares change
-
+648,260
-
Total reported value, excl. options
-
$417,694,000
-
Value change
-
+$20,701,974
-
Put/Call ratio
-
5.6%
-
Number of buys
-
43
-
Number of sells
-
28
-
Price
-
$29.90
Institutional Holders of NEURODERM LTD - ORD SHS as of Q2 2017
As of 30 Jun 2017 NEURODERM LTD - ORD SHS had 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,970,280 shares of stock of the company.
Largest 10 holders included SCOPIA CAPITAL MANAGEMENT LP, MENORA MIVTACHIM HOLDINGS LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., Viking Global Investors LP, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, Redmile Group, LLC, RHENMAN & PARTNERS ASSET MANAGEMENT AB, WELLS FARGO & COMPANY/MN, and SENZAR ASSET MANAGEMENT, LLC.
This table shows 94 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.